INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹276 Cr | ₹103 Cr | ₹55 Cr | ₹53 Cr | ₹25 Cr |
What is the latest Capital Work in Progress ratio of INDOCO REMEDIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹276 Cr |
| Mar2024 | ₹103 Cr |
| Mar2023 | ₹55 Cr |
| Mar2022 | ₹53 Cr |
| Mar2021 | ₹25 Cr |
How is Capital Work in Progress of INDOCO REMEDIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹276 Cr | 168.41 | |
| Mar2024 | ₹103 Cr | 85.71 | |
| Mar2023 | ₹55 Cr | 4.88 | |
| Mar2022 | ₹53 Cr | 110.26 | |
| Mar2021 | ₹25 Cr | - | |
Compare Capital Work in Progress of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,874.2 Cr | -0.9% | -5.2% | -22.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -0.9% |
-5.2% |
-22.5% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses